引用本文:刘前林,周俊东.食管癌放疗联合免疫治疗的研究进展[J].中国临床新医学,2024,17(5):590-594.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 183次   下载 385 本文二维码信息
码上扫一扫!
分享到: 微信 更多
食管癌放疗联合免疫治疗的研究进展
刘前林,周俊东
南京医科大学附属苏州医院放疗科,江苏 215001
摘要:
[摘要] 食管癌是一种常见且具有较高病死率的恶性肿瘤。传统的治疗方法包括手术切除、放疗和化疗,疗效有限。随着免疫治疗的快速发展,越来越多的研究探索食管癌放疗联合免疫治疗的潜力。该文对食管癌放疗联合免疫治疗的研究进展作一综述。
关键词:  食管癌  放射疗法  免疫疗法  免疫检查点抑制剂
DOI:10.3969/j.issn.1674-3806.2024.05.22
分类号:R 734
基金项目:苏州市科技发展计划项目(编号:SKY2023065)
Research progress of radiotherapy combined with immunotherapy for esophageal cancer
LIU Qianlin, ZHOU Jundong
Department of Radiotherapy, the Affiliated Suzhou Hospital of Nanjing Medical University, Jiangsu 215001, China
Abstract:
[Abstract] Esophageal cancer(EC) is a common malignant tumor with high mortality. The traditional treatment methods of EC, including surgical resection, radiotherapy and chemotherapy, have limited efficacy. With the rapid development of immunotherapy, more and more studies have been exploring the potential of radiotherapy combined with immunotherapy for EC. In this paper, the research progress of radiotherapy combined with immunotherapy for EC is reviewed.
Key words:  Esophageal cancer(EC)  Radiotherapy  Immunotherapy  Immune checkpoint inhibitors(ICIs)